---
title: "Top 10 US Stock Gainers (8.17)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296150093.md"
description: "AXT(AXTI) rose 17.55%, with a trading turnover 1.4 Billion USD, and a year-to-date rose 487%. Argenx(ARGX) rose 16.04%, with a trading turnover 672.6 Million USD, and a year-to-date rose 17.5%. Cerebras(CBRS) rose 15.07%, with a trading turnover 3.7 Billion USD, and a year-to-date fell 28%."
datetime: "2026-08-17T22:01:01.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296150093.md)
  - [en](https://longbridge.com/en/news/296150093.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296150093.md)
generator: "portal-rs"
---

# Top 10 US Stock Gainers (8.17)

NASDAQ Composite Index has fell 0.32%, with a year-to-date rose 14.6%; S&P 500 has fell 0.52%, with a year-to-date rose 13.1%; Dow Jones Industrial Average has fell 0.51%, with a year-to-date rose 11.2%.

AXT(AXTI) rose 17.55%, with a trading turnover 1.4 Billion USD, and a year-to-date rose 487%.

Argenx(ARGX) rose 16.04%, with a trading turnover 672.6 Million USD, and a year-to-date rose 17.5%.

Cerebras(CBRS) rose 15.07%, with a trading turnover 3.7 Billion USD, and a year-to-date fell 28%.

### Related Stocks

- [AXTI.US](https://longbridge.com/en/quote/AXTI.US.md)
- [ARGX.US](https://longbridge.com/en/quote/ARGX.US.md)
- [CBRS.US](https://longbridge.com/en/quote/CBRS.US.md)
- [HIVE.US](https://longbridge.com/en/quote/HIVE.US.md)
- [FIGR.US](https://longbridge.com/en/quote/FIGR.US.md)
- [OABI.US](https://longbridge.com/en/quote/OABI.US.md)
- [HTHT.US](https://longbridge.com/en/quote/HTHT.US.md)
- [WOLF.US](https://longbridge.com/en/quote/WOLF.US.md)
- [SMTC.US](https://longbridge.com/en/quote/SMTC.US.md)
- [SNDK.US](https://longbridge.com/en/quote/SNDK.US.md)

## Related News & Research

- [argenx (ENXTBR:ARGX) Hits A Phase 3 Win, Is The Upside Fully Priced?](https://longbridge.com/en/news/296529685.md)
- [A $350 Million Reason to Buy HIVE Digital Technologies Stock](https://longbridge.com/en/news/296392218.md)
- [Argenx Says Phase 3 Alkivia Trial Of Efgartigimod In Autoimmune Myositis Met Primary Endpoint](https://longbridge.com/en/news/296059044.md)
- [Leonard Leblanc Sells 2,000 Shares of AXT (NASDAQ:AXTI) Stock](https://longbridge.com/en/news/296485912.md)
- [These Analysts Boost Their Forecasts On Argenx](https://longbridge.com/en/news/296226998.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**